STOCKTALK _ Biotechs set to boom with clinical trial floodgates open
05 June 2020
A fantastic discussion about Australia’s clinical trial industry.
Jacquie Palmer speaks with the heads of ASX-listed Dimerix Limited and Cynata Therapeutics about how Covid-19 has propelled trial methods forward, and the implications of the pandemic on the future of the sector.
NEWSTALK ZB _ Call for NZ clinical trials after Govt's $37m vaccine spend
27 May 2020
Listen to Managing Director Jacquie Palmer discuss New Zealand’s clinical research potential on NewstalkZB this morning. We’re excited to start a valuable discussion about NZ’s capabilities and opportunities in the clinical sector.
NZ HERALD.CO.NZ _ COVID-19 and New Zealand’s clinical research sector
27 May 2020
"In the global race to find a vaccine, we need populations that have had little exposure to Covid-19 and New Zealand can offer a vital link in the global effort to halt the novel coronavirus," said the group's managing director, Jacquie Palmer.”
MEDICINES NZ _ Clinical trials in NZ worth $1.2 billion
21 May 2020
New Zealand has a window of opportunity to increase market share.
Chief executive of Medicines NZ, Graeme Jarvis, says there has to be a collaborative effort between the industry, clinical research sector and government to make New Zealand a bigger player on the world stage.
Medicines NZ report estimates clinical trials worth $1.2b over 5 years
20 May 2020
A new report independently commissioned by Medicines New Zealand estimates that since 2013, clinical trials of prescription medicines have contributed at least $1.2 billion to the New Zealand economy and have benefitted the health system and Kiwi patients.